Published in BMC Cell Biol on June 17, 2009
Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms. Cell Res (2011) 1.99
Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway. Nat Cell Biol (2015) 1.54
Evolution of the Twist Subfamily Vertebrate Proteins: Discovery of a Signature Motif and Origin of the Twist1 Glycine-Rich Motifs in the Amino-Terminus Disordered Domain. PLoS One (2016) 1.39
IL-6 stabilizes Twist and enhances tumor cell motility in head and neck cancer cells through activation of casein kinase 2. PLoS One (2011) 1.02
Nuclear ubiquitination by FBXL5 modulates Snail1 DNA binding and stability. Nucleic Acids Res (2013) 0.90
Computational modeling of the bHLH domain of the transcription factor TWIST1 and R118C, S144R and K145E mutants. BMC Bioinformatics (2012) 0.88
Low osteogenic differentiation potential of placenta-derived mesenchymal stromal cells correlates with low expression of the transcription factors Runx2 and Twist2. Stem Cells Dev (2013) 0.83
Novel Molecular Markers for Breast Cancer. Biomark Cancer (2016) 0.80
PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer. J Biol Chem (2015) 0.79
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell (2004) 31.38
Nuclear targeting sequences--a consensus? Trends Biochem Sci (1991) 16.65
Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell (1989) 14.24
Transport between the cell nucleus and the cytoplasm. Annu Rev Cell Dev Biol (1999) 13.27
Sequence requirements for nuclear location of simian virus 40 large-T antigen. Nature (1984) 10.52
Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell (1991) 9.96
Nucleocytoplasmic transport. Science (1996) 8.76
A twist code determines the onset of osteoblast differentiation. Dev Cell (2004) 5.40
A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell (1990) 5.39
MyoD family: a paradigm for development? Genes Dev (1990) 5.32
Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif. Science (1990) 4.93
twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev (1995) 4.38
Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat Genet (1997) 3.70
Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A. Cell (1999) 2.90
The effects of variations in the number and sequence of targeting signals on nuclear uptake. J Cell Biol (1988) 2.89
A simple and highly efficient procedure for rescuing autonomous plasmids from yeast. Nucleic Acids Res (1992) 2.70
Putative nuclear localization signals (NLS) in protein transcription factors. J Cell Biochem (1994) 2.16
The twist gene: isolation of a Drosophila zygotic gene necessary for the establishment of dorsoventral pattern. Nucleic Acids Res (1987) 2.07
Consequences of heteromeric interactions among helix-loop-helix proteins. Cell Growth Differ (1993) 1.90
Altered Twist1 and Hand2 dimerization is associated with Saethre-Chotzen syndrome and limb abnormalities. Nat Genet (2005) 1.89
Twist1 dimer selection regulates cranial suture patterning and fusion. Dev Dyn (2006) 1.87
Gene array analysis of osteoblast differentiation. Cell Growth Differ (2001) 1.64
The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, Twist. Mol Cell Biol (1997) 1.56
The binding site of karyopherin alpha for karyopherin beta overlaps with a nuclear localization sequence. Proc Natl Acad Sci U S A (1996) 1.51
The bHLH factors, dHAND and eHAND, specify pulmonary and systemic cardiac ventricles independent of left-right sidedness. Dev Biol (1998) 1.37
Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung. Clin Cancer Res (2004) 1.35
Cell lineage determination and the control of neuronal identity in the neural crest. Cold Spring Harb Symp Quant Biol (1997) 1.35
M-twist is an inhibitor of muscle differentiation. Dev Biol (1994) 1.31
Invertebrate myogenesis: looking back to the future of muscle development. Curr Opin Genet Dev (2001) 1.30
Phosphorylation near nuclear localization signal regulates nuclear import of adenomatous polyposis coli protein. Proc Natl Acad Sci U S A (2000) 1.29
Isolation of two E-box binding factors that interact with the rat tyrosine hydroxylase enhancer. J Biol Chem (1994) 1.18
Saethre-Chotzen mutations cause TWIST protein degradation or impaired nuclear location. Hum Mol Genet (2000) 1.16
Dermo-1, a multifunctional basic helix-loop-helix protein, represses MyoD transactivation via the HLH domain, MEF2 interaction, and chromatin deacetylation. J Biol Chem (2002) 1.06
Twist is required for establishment of the mouse coronal suture. J Anat (2005) 1.02
The mesoderm specification factor twist in the life cycle of jellyfish. Dev Biol (2000) 1.01
A splice variant of E2-2 basic helix-loop-helix protein represses the brain-specific fibroblast growth factor 1 promoter through the binding to an imperfect E-box. J Biol Chem (1998) 1.01
The control of gene expression by regulated nuclear transport. Essays Biochem (2000) 0.95
Functional analysis of natural mutations in two TWIST protein motifs. Hum Mutat (2005) 0.90
Analysis of the inhibition of MyoD activity by ITF-2B and full-length E12/E47. J Biol Chem (2000) 0.80
Cloning of a Twist orthologue from Enchytraeus coronatus (Annelida, Oligochaeta). DNA Seq (2003) 0.80
Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature (2003) 5.94
Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling. Cell (2006) 5.72
Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J Clin Invest (2003) 2.56
A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. Proc Natl Acad Sci U S A (2006) 2.05
Cardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a) activity and impairs cardiac function in mice. Proc Natl Acad Sci U S A (2004) 1.63
The ankyrin-B C-terminal domain determines activity of ankyrin-B/G chimeras in rescue of abnormal inositol 1,4,5-trisphosphate and ryanodine receptor distribution in ankyrin-B (-/-) neonatal cardiomyocytes. J Biol Chem (2002) 1.38
Cell-surface proteomics identifies lineage-specific markers of embryo-derived stem cells. Dev Cell (2012) 1.37
Proteome dynamics during C2C12 myoblast differentiation. Mol Cell Proteomics (2005) 1.36
Cardiovascular proteomics: tools to develop novel biomarkers and potential applications. J Am Coll Cardiol (2006) 1.19
Multidimensional protein identification technology (MudPIT): technical overview of a profiling method optimized for the comprehensive proteomic investigation of normal and diseased heart tissue. J Am Soc Mass Spectrom (2005) 1.13
Enhanced Ca2+ transport and muscle relaxation in skeletal muscle from sarcolipin-null mice. Am J Physiol Cell Physiol (2011) 1.12
An Ryr1I4895T mutation abolishes Ca2+ release channel function and delays development in homozygous offspring of a mutant mouse line. Proc Natl Acad Sci U S A (2007) 1.11
In-depth proteomics of ovarian cancer ascites: combining shotgun proteomics and selected reaction monitoring mass spectrometry. J Proteome Res (2011) 1.11
Peptide separations by on-line MudPIT compared to isoelectric focusing in an off-gel format: application to a membrane-enriched fraction from C2C12 mouse skeletal muscle cells. J Proteome Res (2009) 1.11
Large-scale characterization and analysis of the murine cardiac proteome. J Proteome Res (2009) 1.08
Cardiac-specific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction. Proc Natl Acad Sci U S A (2006) 1.08
Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer. Mol Cell Proteomics (2012) 1.08
Constitutively active calcineurin induces cardiac endoplasmic reticulum stress and protects against apoptosis that is mediated by alpha-crystallin-B. Proc Natl Acad Sci U S A (2010) 1.03
Tbx5-dependent pathway regulating diastolic function in congenital heart disease. Proc Natl Acad Sci U S A (2008) 1.02
Ankyrins. J Cell Sci (2002) 1.01
Genes, proteins and complexes: the multifaceted nature of FHL family proteins in diverse tissues. J Cell Mol Med (2010) 1.01
Identification of an FHL1 protein complex containing ACTN1, ACTN4, and PDLIM1 using affinity purifications and MS-based protein-protein interaction analysis. Mol Biosyst (2011) 0.95
Structural determination of the phosphorylation domain of the ryanodine receptor. FEBS J (2012) 0.95
Endoplasmic reticulum protein targeting of phospholamban: a common role for an N-terminal di-arginine motif in ER retention? PLoS One (2010) 0.94
HSP70 binds to the fast-twitch skeletal muscle sarco(endo)plasmic reticulum Ca2+ -ATPase (SERCA1a) and prevents thermal inactivation. J Biol Chem (2004) 0.93
Translational analysis of mouse and human placental protein and mRNA reveals distinct molecular pathologies in human preeclampsia. Mol Cell Proteomics (2011) 0.92
Identification of biochemical adaptations in hyper- or hypocontractile hearts from phospholamban mutant mice by expression proteomics. Proc Natl Acad Sci U S A (2004) 0.92
Predict, prevent and personalize: Genomic and proteomic approaches to cardiovascular medicine. Can J Cardiol (2007) 0.90
Calnexin silencing in mouse neonatal cardiomyocytes induces Ca2+ cycling defects, ER stress, and apoptosis. J Cell Physiol (2014) 0.89
α-Crystallin B prevents apoptosis after H2O2 exposure in mouse neonatal cardiomyocytes. Am J Physiol Heart Circ Physiol (2012) 0.89
The cardiovascular exosome: current perspectives and potential. Proteomics (2013) 0.87
Multiple regulatory events controlling the expression and localization of utrophin in skeletal muscle fibers: insights into a therapeutic strategy for Duchenne muscular dystrophy. J Physiol Paris (2001) 0.85
Recent advances in cardiovascular proteomics. J Proteomics (2012) 0.84
Identification of novel ryanodine receptor 1 (RyR1) protein interaction with calcium homeostasis endoplasmic reticulum protein (CHERP). J Biol Chem (2011) 0.84
Pilot study identifying myosin heavy chain 7, desmin, insulin-like growth factor 7, and annexin A2 as circulating biomarkers of human heart failure. Proteomics (2013) 0.82
Use of colloidal silica-beads for the isolation of cell-surface proteins for mass spectrometry-based proteomics. Methods Mol Biol (2011) 0.81
Systems analysis reveals down-regulation of a network of pro-survival miRNAs drives the apoptotic response in dilated cardiomyopathy. Mol Biosyst (2014) 0.80
Swelling-activated Cl- currents and intracellular CLC-3 are involved in proliferation of human pulmonary artery smooth muscle cells. J Hypertens (2014) 0.80
A method for the direct identification of differentiating muscle cells by a fluorescent mitochondrial dye. PLoS One (2011) 0.79
Proteomics-based investigations of animal models of disease. Proteomics Clin Appl (2008) 0.79
Proteome analysis of mouse model systems: A tool to model human disease and for the investigation of tissue-specific biology. J Proteomics (2010) 0.78
Uncovering early markers of cardiac disease by proteomics: avoiding (heart) failure! Expert Rev Proteomics (2005) 0.78
Large-scale characterization of the murine cardiac proteome. Methods Mol Biol (2013) 0.78
Proteomic analysis of human fetal atria and ventricle. J Proteome Res (2014) 0.78
A proteomic interrogation of Cryptococcus neoformans: interaction networks for calcineurin in a heated environment. Expert Rev Proteomics (2012) 0.75
Clinical proteomics: getting to the heart of the matter. Circ Cardiovasc Genet (2012) 0.75